MONTREAL, May 12, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:  GUD) (“Knight”), a pan-American (ex-USA) pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026 at 9:00 am ET at the InterContinental New York Barclay hotel in New York City. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.’s shares trade on the TSX under the...

CHANTILLY, Va., May 12, 2026 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was selected by the United States Air Force (USAF) and its 75th Civil Engineer Group at Hill Air Force Base for a multiple award task order contract (MATOC) to provide architect-engineer services across the installation. The $136 million ceiling value contract consists of an 8.5-year performance period and represents new work for the company. Under the contract, Parsons will compete for task orders to deliver architect-engineer services supporting a range of infrastructure needs at Hill AFB. The scope of work includes the design, alteration, and repair of airfields, grounds, roads, buildings, structures, and utilities, as well as feasibility and traffic studies and cybersecurity-related design services that support secure,...

Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global investors. Proceeds are expected to fund the Company through 2027, including completion of the ongoing Phase 1b clinical trial in Alzheimer’s disease (AD). PRECISE-AD Phase 1b trial is fully enrolled and progressing on schedule, with the blinded 6-month interim analysis anticipated in early Q3 2026 and 12-month top-line data anticipated in early 2027.  The planned interim analysis is expected to include a qualitative assessment of aggregated safety data, including amyloid-related imaging abnormalities (ARIA) incidence, as well as key biomarker trends across all study participants at the 6-month timepoint.Cambridge, Massachusetts, May 12, 2026 (GLOBE NEWSWIRE) — ProMIS Neurosciences...

Grows Revenue 3% and Updates 2026 Outlook MARKHAM, Ontario, May 12, 2026 (GLOBE NEWSWIRE) — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, today announced its financial results for the first quarter 2026. First Quarter HighlightsSystem-wide sales(1) were $375.2 million, an increase of 2.5% versus Q1 2025. Same-store sales growth(1) was flat. Revenue was $287.9 million, up 3.2% versus Q1 2025. Adjusted EBITDA(2) was $55.9 million, down 4.8% versus Q1 2025, representing 19.4% of revenue. Operating income was $34.9 million, down 6.6% versus Q1 2025. Adjusted Net Income(2) was $21.6 million or $0.31 per diluted share(3), compared to $25.4 million or $0.36 per diluted share, respectively, in Q1 2025. Net income was $20.0 million, down 7.9%...

Newport Beach, CA, May 12, 2026 (GLOBE NEWSWIRE) — Bimergen Energy Corporation (NYSE American: BESS, BESS.WS), a developer, owner, and operator of utility-scale and distributed battery energy storage systems (BESS) across the United States, today announced that the Company will participate in the LD Micro 16th Annual Invitational, taking place May 17-19 , 2026, at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Bimergen’s Co-CEO, Bob Brilon, will deliver a corporate presentation on Monday, May 18th at 3:30 pm Pacific Time, as well as conduct one-on-one meetings with investors during the conference. The LD Micro Invitational is one of the premier investor conferences focused on microcap companies, bringing together leading institutional investors and emerging growth companies for presentations and networking opportunities. Bimergen...